Member Info for Gemlotte

Yes i was impressed with meeting,. Like the bit about future divided.hopefully a new beginning, bought some more just after, wish directors would also buy directly,.

Presentation tomorrow, have you put your questions in..
Lets hope it will spark the shares into life.

I'm sure they have seen, but just in case i sent the link to them

Same here.
All the years I've given them the benefit of the dought, unfortunately the people who have said there a lifestyle company are unfortunately right..

Shouldn't be long before Sym issue a trading update, be interesting to see if there's a update on guidance

Close to £400000 of sales in 2022 with Rivulis Irrigation Ltd and expecting more by year end. Compared with £50000 for 2021.

Excellent news this morning with reassuring sale figures

Pretty bullish if then,if we can believe him

Fantastic news this morning, just what has been needed.

Bloody hope so...

Very quiet on here, with the pound falling against the dollar the divi must be close to 6 percent, good for income seekers

Lets hope for something substantial soon to get the share price up
Very odd the deal they had with meditech who were going to buy into the company, not really explained why they pulled out

Thanks Mr Tooley

Thanks Trojan.
Do you know the date that interview happened?

Wonder if Meditech looking at taking this over,half the price that it was going to subscribe to.

Last years results should be out this week, heres hoping for some good news

Big spread today, can't remember seeing so wide , do they not want to create a market!

Buy the company and put me out of my misery??

This was taken from the RNS from the 2nd August 2021.

Within six months, Meditech plans to acquire between 2.5% and 20% of Symphony's total issued share capital. The shares can be bought in the open market, by private treaty, or at Symphony's discretion, via the issue of new shares at no less than 35p each.

Wonder how many they've bought?

The new business pipeline of d2p technologies and PPE/gloves currently totals over 100 projects for which management estimate if successfully commercialised would generate in excess of $40 million of recurring annual revenues.